Jose Mourinho claims Chelsea’s Diego Costa will prove a bargain buy after the Spain striker marked his home debut with a clinical brace in the 2-0 friendly win over Real Sociedad.
Mourinho splashed out £32 million (US$53 million) to lure Costa from Spanish champions Atletico Madrid and the Blues boss is convinced even that hefty price tag will look cheap by the end of the season.
The 25-year-old certainly looks capable of justifying Mourinho’s faith after making a confident bow for his new club at Stamford Bridge in London.
Photo: Reuters
He took just 57 seconds to open the scoring with a cool finish from an acute angle and bagged his second with a tap-in after Andre Schurrle’s shot hit the post in the seventh minute.
As well as his goals, Mourinho was also impressed with the way Costa linked with attacking midfield trio Schurrle, Eden Hazard and Cesc Fabregas, while working tirelessly to close down Sociedad when they were in possession.
His qualities look ideally suited to the English Premier League and Mourinho said: “Diego is a team player, he works a lot, he is not just about goals. He is about defensive work, his mentality, his ambition.”
Photo: Reuters
“This is why we didn’t buy a striker in the last transfer window — we were waiting for him,” Mourinho said. “He looks very adapted to his teammates and the style of play. I won’t say he is adapted to the Premier League yet because it is a very difficult job to be a striker in this country, but hopefully he does well. You can consider that it is a bargain because the market is crazy. The values for strikers are very high, so for a young striker like him, a champion in Spain and a Champions League finalist, you can say the price Chelsea paid is very much in our favor.”
After finishing last season without a trophy, Mourinho has carried out an £80 million overhaul of his squad, with Costa, Fabregas and Filipe Luis the headline signings.
The Portuguese coach is delighted with his new acquisitions and, although he refused to bill Chelsea as title favorites, he predicted great things for the club in the long term.
“I think we bought three players in Filipe, Diego and Fabregas in the best stage for a football player between 25 and 30,” he said. “They are three experienced players with good qualities to improve immediately our team. They are ready, so normally our team will improve, the squad has improved for sure. We showed some qualities today that in the past we didn’t.”
“No manager has a perfect squad, but we like very much our squad, we don’t say they are special, but it is a squad that has big possibilities for the next five years,” he added.
With next Monday’s Premier League opener against Burnley fast approaching, Mourinho’s only dilemma has been deciding which of Petr Cech and Thibaut Courtois will start in goal at Turf Moor.
Belgian youngster Courtois, so impressive on loan at Atletico last season, started against Sociedad and Mourinho says he has chosen his No. 1 for the opening day.
“Courtois played 90 minutes because he was injured and didn’t play last week,” Mourinho said. “The decision that he played today is not me saying he is the first choice for Monday. I know who will play. The players don’t know. They have to know first. I will tell them on Sunday.”
Mourinho also revealed that Blues legend Didier Drogba, back from Galatasaray for a second tour of duty at the Bridge, could still recover from his ankle injury in time to feature against Burnley.
“Didier is good, I don’t want to say ready for Monday, but with the quality of our medical department and the mentally he has, I’m not saying it is impossible for him to recover for Monday either,” Mourinho added.
Bayer 04 Leverkusen go into today’s match at TSG 1899 Hoffenheim stung from their first league defeat in 16 months. Leverkusen were beaten 3-2 at home by RB Leipzig before the international break, the first loss since May last year for the reigning league and cup champions. While any defeat, particularly against a likely title rival, would have disappointed coach Xabi Alonso, the way in which it happened would be most concerning. Just as they did in the Supercup against VfB Stuttgart and in the league opener to Borussia Moenchengladbach, Leverkusen scored first, but were pegged back. However, while Leverkusen rallied late to
If all goes well when the biggest marathon field ever gathered in Australia races 42km through the streets of Sydney on Sunday, World Marathon Majors (WMM) will soon add a seventh race to the elite series. The Sydney Marathon is to become the first race since Tokyo in 2013 to join long-established majors in New York, London, Boston, Berlin and Chicago if it passes the WMM assessment criteria for the second straight year. “We’re really excited for Sunday to arrive,” race director Wayne Larden told a news conference in Sydney yesterday. “We’re prepared, we’re ready. All of our plans look good on
The lights dimmed and the crowd hushed as Karoline Kristensen entered for her performance. However, this was no ordinary Dutch theater: The temperature was 80°C and the audience naked apart from a towel. Dressed in a swimsuit and to the tune of emotional music, the 21-year-old Kristensen started her routine, performed inside a large sauna, with a bed of hot rocks in the middle. For a week this month, a group of wellness practitioners, called “sauna masters,” are gathering at a picturesque health resort in the Netherlands to compete in this year’s Aufguss world sauna championships. The practice takes its name from a
When details from a scientific experiment that could have helped clear Russian figure skater Kamila Valieva landed at the World Anti-Doping Agency (WADA), the leader of the organization’s reaction was unequivocal: “We have to stop that urgently,” he wrote. No mention of the test ever became public and Valieva’s defense at the Court of Arbitration for Sport (CAS) went on without it. What effect the information could have had on Valieva’s case is unclear, but without it, the skater, then 15 years old, was eventually disqualified from the 2022 Winter Olympics after testing positive for a banned heart medication that would later